565 related articles for article (PubMed ID: 31253192)
1. MicroRNA-486-3p functions as a tumor suppressor in oral cancer by targeting DDR1.
Chou ST; Peng HY; Mo KC; Hsu YM; Wu GH; Hsiao JR; Lin SF; Wang HD; Shiah SG
J Exp Clin Cancer Res; 2019 Jun; 38(1):281. PubMed ID: 31253192
[TBL] [Abstract][Full Text] [Related]
2. MiR-30a and miR-379 modulate retinoic acid pathway by targeting DNA methyltransferase 3B in oral cancer.
Shiah SG; Hsiao JR; Chang HJ; Hsu YM; Wu GH; Peng HY; Chou ST; Kuo CC; Chang JY
J Biomed Sci; 2020 Apr; 27(1):46. PubMed ID: 32238162
[TBL] [Abstract][Full Text] [Related]
3. Suppressing miR-199a-3p by promoter methylation contributes to tumor aggressiveness and cisplatin resistance of ovarian cancer through promoting DDR1 expression.
Deng Y; Zhao F; Hui L; Li X; Zhang D; Lin W; Chen Z; Ning Y
J Ovarian Res; 2017 Jul; 10(1):50. PubMed ID: 28743276
[TBL] [Abstract][Full Text] [Related]
4. MiR-376c-3p regulates the proliferation, invasion, migration, cell cycle and apoptosis of human oral squamous cancer cells by suppressing HOXB7.
Wang K; Jin J; Ma T; Zhai H
Biomed Pharmacother; 2017 Jul; 91():517-525. PubMed ID: 28482289
[TBL] [Abstract][Full Text] [Related]
5. miR-23a-3p suppresses cell proliferation in oral squamous cell carcinomas by targeting FGF2 and correlates with a better prognosis: miR-23a-3p inhibits OSCC growth by targeting FGF2.
Chen F; Qi S; Zhang X; Wu J; Yang X; Wang R
Pathol Res Pract; 2019 Apr; 215(4):660-667. PubMed ID: 30606659
[TBL] [Abstract][Full Text] [Related]
6. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
Wang X; Li H; Shi J
Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-16 functions as a tumor-suppressor gene in oral squamous cell carcinoma by targeting AKT3 and BCL2L2.
Wang X; Li GH
J Cell Physiol; 2018 Dec; 233(12):9447-9457. PubMed ID: 30136280
[TBL] [Abstract][Full Text] [Related]
8. MiR-223-3p inhibits proliferation and metastasis of oral squamous cell carcinoma by targeting SHOX2.
Sun C; Liu XH; Sun YR
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6927-6934. PubMed ID: 31486492
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
Cai Z; Hao XY; Liu FX
Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
[TBL] [Abstract][Full Text] [Related]
10. Acquisition cancer stemness, mesenchymal transdifferentiation, and chemoresistance properties by chronic exposure of oral epithelial cells to arecoline.
Wang TY; Peng CY; Lee SS; Chou MY; Yu CC; Chang YC
Oncotarget; 2016 Dec; 7(51):84072-84081. PubMed ID: 27557511
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-361-3p is a potent therapeutic target for oral squamous cell carcinoma.
Ogawa H; Nakashiro KI; Tokuzen N; Kuribayashi N; Goda H; Uchida D
Cancer Sci; 2020 May; 111(5):1645-1651. PubMed ID: 32086979
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-375 Inhibits Growth and Enhances Radiosensitivity in Oral Squamous Cell Carcinoma by Targeting Insulin Like Growth Factor 1 Receptor.
Zhang B; Li Y; Hou D; Shi Q; Yang S; Li Q
Cell Physiol Biochem; 2017; 42(5):2105-2117. PubMed ID: 28810236
[TBL] [Abstract][Full Text] [Related]
13. Effects of arecoline on proliferation of oral squamous cell carcinoma cells by dysregulating c-Myc and miR-22, directly targeting oncostatin M.
Chuerduangphui J; Ekalaksananan T; Chaiyarit P; Patarapadungkit N; Chotiyano A; Kongyingyoes B; Promthet S; Pientong C
PLoS One; 2018; 13(1):e0192009. PubMed ID: 29385191
[TBL] [Abstract][Full Text] [Related]
14. MiR-133a-3p Inhibits Oral Squamous Cell Carcinoma (OSCC) Proliferation and Invasion by Suppressing COL1A1.
He B; Lin X; Tian F; Yu W; Qiao B
J Cell Biochem; 2018 Jan; 119(1):338-346. PubMed ID: 28569392
[TBL] [Abstract][Full Text] [Related]
15. MiR-92a regulates oral squamous cell carcinoma (OSCC) cell growth by targeting FOXP1 expression.
Guo J; Wen N; Yang S; Guan X; Cang S
Biomed Pharmacother; 2018 Aug; 104():77-86. PubMed ID: 29772443
[TBL] [Abstract][Full Text] [Related]
16. MiR-127-3p targets KIF3B to inhibit the development of oral squamous cell carcinoma.
Ji L; Zhu ZN; He CJ; Shen X
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):630-640. PubMed ID: 30720171
[TBL] [Abstract][Full Text] [Related]
17. miRNA-99b-3p functions as a potential tumor suppressor by targeting glycogen synthase kinase-3β in oral squamous cell carcinoma Tca-8113 cells.
He K; Tong D; Zhang S; Cai D; Wang L; Yang Y; Gao L; Chang S; Guo B; Song T; Li A; Huang C
Int J Oncol; 2015 Oct; 47(4):1528-36. PubMed ID: 26315788
[TBL] [Abstract][Full Text] [Related]
18. Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening.
He L; Ping F; Fan Z; Zhang C; Deng M; Cheng B; Xia J
Biomed Pharmacother; 2020 Jan; 121():109553. PubMed ID: 31704611
[TBL] [Abstract][Full Text] [Related]
19. miR-138 suppresses the proliferation of oral squamous cell carcinoma cells by targeting Yes-associated protein 1.
Xu R; Zeng G; Gao J; Ren Y; Zhang Z; Zhang Q; Zhao J; Tao H; Li D
Oncol Rep; 2015 Oct; 34(4):2171-8. PubMed ID: 26239136
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of microRNA-27b-3p via aberrant DNA methylation contributes to malignant behavior of gastric cancer cells by targeting GSPT1.
Zhang C; Zou Y; Dai DQ
Biomed Pharmacother; 2019 Nov; 119():109417. PubMed ID: 31539861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]